Casdin Capital, LLC Orchard Therapeutics PLC Transaction History

Casdin Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.23 $2.99 Million - $5.74 Million	-2,575,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $1.43 Million - $2.75 Million	-640,434 Reduced 19.92%	2,575,000 $5.92 Million
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $14.1 Million - $29.2 Million	3,215,434 New	3,215,434 $23.3 Million
Q4 2020 Feb 16, 2021	SELL	$3.86 - $5.07 $7.22 Million - $9.48 Million	-1,870,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.11 - $6.45 $904,200 - $1.42 Million	220,000 Added 13.33%	1,870,000 $7.69 Million
Q2 2020 Aug 14, 2020	BUY	$5.75 - $11.99 $3.88 Million - $8.09 Million	675,000 Added 69.23%	1,650,000 $9.9 Million
Q1 2020 May 15, 2020	BUY	$5.65 - $15.71 $875,750 - $2.44 Million	155,000 Added 18.9%	975,000 $7.34 Million
Q4 2019 Feb 14, 2020	BUY	$10.15 - $15.58 $5.18 Million - $7.95 Million	510,000 Added 164.52%	820,000 $11.3 Million
Q3 2019 Nov 12, 2019	BUY	$11.88 - $16.72 $2.49 Million - $3.51 Million	210,000 Added 210.0%	310,000 $3.68 Billion
Q2 2019 Aug 13, 2019	BUY	$13.2 - $20.63 $1.32 Million - $2.06 Million	100,000 New	100,000 $0

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.